Diagnos Laboratorium Utama Tbk. vs Nusa Palapa Gemilang Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Nusa Palapa Gemilang Tbk. trades at Rp58 (market cap 184.69B, 6.45M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Nusa Palapa Gemilang Tbk. is more actively traded (6.45M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | NPGF | |
|---|---|---|
Market Cap | 310.75B | 184.69B |
Volume | 963.6K | 6.45M |
Lot | 9.64K | 64.5K |
Turnover | 217.67M | 366.91M |
Average Price | 225.89 | 56.89 |
Value | 217.67M | 366.91M |
Indicative Equilibrium Price | 226 | 58 |
Indicative Equilibrium Volume | 1K | 3.02K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Nusa Palapa Gemilang Tbk (the Company) was established based on Notarial Deed No. 111 of Untung Darmosoewirjo S.H., dated November 29, 2001, a Notary in Surabaya.
Read more on NPGF →